◀ Back to IL2
IL2 — MAPK3
Pathways - manually collected, often from reviews:
-
NCI Pathway Database Regulation of Telomerase:
Erk1-2 (MAPK3/MAPK1)
→
IL2 (IL2)
(modification, collaborate)
Kawauchi et al., J Immunol 2005
Evidence: assay, physical interaction
-
NCI Pathway Database IL2-mediated signaling events:
Erk1-2-active (MAPK3/MAPK1)
→
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GRB2/SOS1/GAB2 complex (IL2RA-IL2RB-IL2RG-IL2-JAK1-LCK-JAK3-SHC1-GRB2-SOS1-GAB2)
(modification, collaborate)
Gadina et al., J Biol Chem 2000, Arnaud et al., Biochem J 2004, Arnaud et al., J Immunol 2004, Gadina et al., J Immunol 1998, Gadina et al., J Immunol 1999
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database IL2-mediated signaling events:
Erk1-2-active (MAPK3/MAPK1)
→
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GRB2/SOS1/GAB2/ERK1-2 complex (IL2RA-IL2RB-IL2RG-IL2-JAK1-LCK-JAK3-SHC1-GRB2-SOS1-GAB2-MAPK3_MAPK1)
(modification, collaborate)
Gadina et al., J Biol Chem 2000, Arnaud et al., Biochem J 2004, Arnaud et al., J Immunol 2004, Gadina et al., J Immunol 1998, Gadina et al., J Immunol 1999
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database IL2-mediated signaling events:
Erk1-2-active (MAPK3/MAPK1)
→
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GRB2/SOS1/GAB2/SHP2 complex (IL2RA-IL2RB-IL2RG-IL2-JAK1-LCK-JAK3-SHC1-GRB2-SOS1-GAB2-PTPN11)
(modification, collaborate)
Gadina et al., J Biol Chem 2000, Arnaud et al., Biochem J 2004, Arnaud et al., J Immunol 2004, Gadina et al., J Immunol 1998, Gadina et al., J Immunol 1999
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database IL2-mediated signaling events:
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GRB2/SOS1/GAB2 complex (IL2RA-IL2RB-IL2RG-IL2-JAK1-LCK-JAK3-SHC1-GRB2-SOS1-GAB2)
→
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GRB2/SOS1/GAB2/ERK1-2 complex (IL2RA-IL2RB-IL2RG-IL2-JAK1-LCK-JAK3-SHC1-GRB2-SOS1-GAB2-MAPK3_MAPK1)
(modification, collaborate)
Gadina et al., J Biol Chem 2000, Arnaud et al., Biochem J 2004, Arnaud et al., J Immunol 2004, Gadina et al., J Immunol 1998, Gadina et al., J Immunol 1999
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database IL2-mediated signaling events:
SHP2 (PTPN11)
→
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GRB2/SOS1/GAB2/ERK1-2 complex (IL2RA-IL2RB-IL2RG-IL2-JAK1-LCK-JAK3-SHC1-GRB2-SOS1-GAB2-MAPK3_MAPK1)
(modification, collaborate)
Gadina et al., J Biol Chem 2000, Arnaud et al., Biochem J 2004, Arnaud et al., J Immunol 2004, Gadina et al., J Immunol 1998, Gadina et al., J Immunol 1999
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database IL2-mediated signaling events:
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GRB2/SOS1/GAB2/ERK1-2 complex (IL2RA-IL2RB-IL2RG-IL2-JAK1-LCK-JAK3-SHC1-GRB2-SOS1-GAB2-MAPK3_MAPK1)
→
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GRB2/SOS1/GAB2/SHP2 complex (IL2RA-IL2RB-IL2RG-IL2-JAK1-LCK-JAK3-SHC1-GRB2-SOS1-GAB2-PTPN11)
(modification, collaborate)
Gadina et al., J Biol Chem 2000, Arnaud et al., Biochem J 2004, Arnaud et al., J Immunol 2004, Gadina et al., J Immunol 1998, Gadina et al., J Immunol 1999
Evidence: mutant phenotype, assay, physical interaction
Text-mined interactions from Literome
Varga et al., Int Immunol 1999
:
Suppression of activation of both MEK and p38
MAPK resulted in significant inhibition of
IL-2 gene expression
Gadina et al., J Biol Chem 2000
:
We previously identified SHP-2 ( Src homology 2 domain containing phosphatase 2 ) as an important intermediate in
IL-2 dependent
MAPK activation and showed its association with a 98-kDa phosphoprotein in response to IL-2
Wei et al., Immunobiology 2000
:
IL-2 induces the association of IL-2Rbeta, lyn, and MAP kinase
ERK-1 in human neutrophils
McDermott et al., J Biol Chem 2002
:
Ras participates in the
activation of p38
MAPK by
interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1
Ling et al., Crit Care Med 2002
:
In contrast to its effects on the janus kinase/STAT pathways,
interleukin-6 activation of MAP kinases (
extracellular signal regulated kinase-1 , extracellular signal regulated kinase-2, and p38 ) was unaffected by endotoxin
Irusen et al., J Allergy Clin Immunol 2002
(Asthma) :
Activation of p38
MAPK by
IL-2 and IL-4, as shown by means of phosphorylation of activated transcription factor 2, resulted in GR phosphorylation and reduced dexamethasone repression of LPS stimulated GM-CSF release
Yan et al., J Biol Chem 2002
:
This model probiotic also inhibits
activation of the pro-apoptotic
p38/mitogen activated protein kinase by tumor necrosis factor,
interleukin-1alpha , or gamma-interferon
Kovanen et al., J Biol Chem 2003
(MAP Kinase Signaling System) :
In IL-2 dependent CTLL-2 cells, we show that
IL-2 induced
ERK-1/2 activity was inhibited by wild type DUSP5 but markedly increased by an inactive form of DUSP5, suggesting a negative feedback role for DUSP5 in IL-2 signaling
Jee et al., J Invest Dermatol 2002
(Carcinoma, Basal Cell...) :
Next,
interleukin-6 stimulation elicited extracellular signal regulated kinase activation in basal cell carcinoma cells, and the
mitogen activated protein kinase inhibitor, PD98059, could
affect this response without affecting the interleukin-6-medi ated Mcl-1 upregulation
Ruhul Amin et al., Oncogene 2002
:
In addition, PP1 substantially inhibited the
IL-2beta- and TNFalpha dependent
activation of
Erk 1/2 and Akt
García-Lora et al., Cancer Immunol Immunother 2003
:
Different
regulation of PKC isoenzymes and
MAPK by PSK and
IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line
Lundin Brockdorff et al., Cytokine 2002
(MAP Kinase Signaling System...) :
SHP2 regulates
IL-2 induced
MAPK activation, but not Stat3 or Stat5 tyrosine phosphorylation, in cutaneous T cell lymphoma cells ... The cells transfected with inactive SHP2 showed reduced MAPK activation upon IL-2 stimulation, suggesting that SHP2 upregulates
IL-2 induced
MAPK activation in T cells ... In conclusion, we show for the first time that SHP2 positively regulates
IL-2 induced
MAPK activation in malignant T cells
Faubert Kaplan et al., Int Immunopharmacol 2003
:
Collectively, these studies suggest that cannabinoid induced inhibition of
IL-2 in PMA/Io stimulated splenocytes might be
due , in part, to inhibition of ERK
MAPK activation
Kotturi et al., J Biol Chem 2003
:
We found that treatment of T lymphocytes with ( +/- ) Bay K 8644 increased intracellular Ca2+ and
induced the activation of phosphoextracellular regulated kinase 1/2 (
Erk1/2 ), whereas nifedipine blocked Ca2+ influx, the activity of Erk1/2 and nuclear factor of activated T cells ( NFAT ),
interleukin-2 (IL-2) production, and IL-2 receptor expression
Veiopoulou et al., Neuroimmunomodulation 2004
(MAP Kinase Signaling System) :
Here we have examined the
role of p38
MAPK on
IL-2 and IL-10 production following activation of human CD4+ T cells or of the leukemic cell line Hut-78, with either plate bound anti-CD3 in the presence or absence of soluble anti-CD28 ( plCD3, plCD3/sCD28 ), or with cross linked anti-CD3 and anti-CD28 ( crsCD3+CD28 ), or with PMA plus ionomycin
Mason et al., Infect Immun 2004
:
TRAF6 dependent
mitogen activated protein kinase activation differentially
regulates the production of
interleukin-12 by macrophages in response to Toxoplasma gondii
Fang et al., J Immunol 2005
(Calcium Signaling...) :
Anthrax lethal toxin blocks
MAPK kinase
dependent IL-2 production in CD4+ T cells
Dillon et al., Mol Cell Biol 2005
:
The
mitogen activated protein kinase extracellular signal regulated kinase ( ERK ) is activated following engagement of the T-cell receptor and is
required for
interleukin 2 (IL-2) production and T-cell proliferation
Yang et al., Clin Exp Immunol 2006
(MAP Kinase Signaling System...) :
Differential
regulation of
interleukin-12 and tumour necrosis factor-alpha by phosphatidylinositol 3-kinase and
ERK 1/2 pathways during Mycobacterium tuberculosis infection
Kogkopoulou et al., J Leukoc Biol 2006
:
Conditional up-regulation of
IL-2 production by p38 MAPK inactivation is
mediated by increased
Erk1/2 activity
Molinero et al., Hum Immunol 2006
:
IL-2 effect involved Jak3/STAT5, p38
MAPK , p70 ( 56 ) kinase, Lck/fyn kinases, and NF-kappaB
Suzuki et al., Cytokine 2008
(Hemorrhage...) :
Two hours thereafter, T cell production of
IL-2 and IFN-gamma and
activation of
MAPK ( p38, ERK-1/2 and JNK ) were determined
Hamdi et al., Biochim Biophys Acta 2008
(MAP Kinase Signaling System) :
As a functional
consequence of this PLD2 dependent
MAPK activation,
interleukin-2 production evoked by PMA/ionomycin stimulation or CD3/CD28 engagement was enhanced in the two T-cell lines overexpressing PLD2 ... As a functional
consequence of this PLD2 dependent
MAPK activation,
interleukin-2 production evoked by PMA/ionomycin stimulation or CD3/CD28 engagement was enhanced in the two T-cell lines overexpressing PLD2
Kovanen et al., J Biol Chem 2008
(MAP Kinase Signaling System) :
IL-2 activates
mitogen activated protein kinase ( MAPK ), phosphatidylinositol 3-kinase, and signal transducer and activator of transcription ( STAT ) pathways and modulates expression of target genes
Kim et al., Biochem Biophys Res Commun 2009
:
Hph-1-ZAP-70-Y319F inhibited the phosphorylation of ZAP-70-Tyr319, LAT-Tyr191, and p44/42
MAPK induced by TcR stimulation, NFAT- and AP-1 mediated gene transcription, and the induction of CD69 expression and
IL-2 secretion
Conrad et al., Cell Signal 2009
:
Collectively, these results suggest that during Thy-1 induced T-lymphocyte activation, ERK1/2 and JNK promoted IL-2 production whereas p38
MAPK negatively
regulated IL-2 expression ... Collectively, these results suggest that during Thy-1 induced T-lymphocyte activation,
ERK1/2 and JNK
promoted IL-2 production whereas p38 MAPK negatively regulated IL-2 expression ...
IL-2R signalling
involved both p38
MAPK and JNK in CTLL-2 cells, whereas p38 MAPK was most important for IL-2R signalling in primary T-lymphocytes
Yu et al., Am J Physiol Cell Physiol 2010
:
Previous research has shown that shockwave treatment affects T-cell function,
enhancing T-cell proliferation and
IL-2 expression by activating p38
mitogen activated protein kinase ( MAPK ) signaling
Munitz et al., Gastroenterology 2010
(Colitis...) :
In vitro analysis showed increased production of proinflammatory cytokines ( interleukin-6,
interleukin-1beta , and tumor necrosis factor alpha ) and
activation of
MAPK and NF-kappaB in Pirb-/- macrophages following bacterial activation
Glossop et al., J Tissue Eng Regen Med 2010
:
In a previous gene expression study, we reported a potentially important
role for mitogen activated protein kinase kinase kinase 8 ( MAP3K8 ) and
interleukin-1ß ( IL-1B ) in
MAPK signalling in MSCs exposed to fluid shear stress
Woehrle et al., J Leukoc Biol 2010
:
Blocking or silencing of Panx1 or of P2X1, P2X4, or P2X7 receptors blunts HS-induced p38
MAPK activation and the stimulatory
effects of HS on TCR/CD28 induced
IL-2 gene transcription
Rasheed et al., Arthritis Res Ther 2010
(Osteoarthritis) :
Pomegranate extract inhibits the
interleukin-1ß induced
activation of MKK-3,
p38a-MAPK and transcription factor RUNX-2 in human osteoarthritis chondrocytes
Dauphinee et al., Am J Physiol Heart Circ Physiol 2011
:
We find that Ga ( i/o ) -mediated activation of the
MAPK is
independent of the canonical MyD88,
interleukin-1 receptor associated kinase, and tumor necrosis factor receptor associated factor 6 signaling cascade in LPS stimulated cells
Byun et al., Biochem Biophys Res Commun 2012
(Inflammation) :
In addition, EGCG treated DCs inhibited lipopolysaccharide (LPS) induced production of pro-inflammatory cytokines ( tumor necrosis factor [TNF ] -a,
interleukin [ IL]-1ß, and IL-6 ) and
activation of mitogen activated protein kinases ( MAPKs ), e.g.,
extracellular signal regulated kinase 1/2 ( ERK1/2 ), p38, c-Jun N-terminal kinase (JNK), and nuclear factor ?B ( NF-?B ) p65 translocation through 67LR
Tormos et al., Hepatology 2013
(Chronic Disease...) :
p38a mitogen activated protein kinases (
MAPK ) may be essential in the up-regulation of proinflammatory cytokines and can be
activated by transforming growth factor ß, tumor necrosis factor-a,
interleukin-1ß , and oxidative stress
Fairhurst et al., Immunology 1993
:
Activation of
mitogen activated protein kinase/ERK-2 in phytohaemagglutin in blasts by recombinant
interleukin-2 : contrasting features with CD3 activation
Franklin et al., Clin Immunol Immunopathol 1996
:
Activation of p42erk2
MAPK and p90rsk by
IL-2 occurs independently of protein kinase C ... Stimulation of the human interleukin-2 (IL-2) dependent cell line, Kit225, with
IL-2 resulted in the rapid activation of microtubule associated protein-2 kinase (
MAPK ), as demonstrated by the tyrosine phosphorylation of p42erk2, the reduced mobility of MAPK in SDS-PAGE gels, and the increased ability of lysates from these cells to phosphorylate myelin basic protein ... Stimulation of the human interleukin-2 (IL-2) dependent cell line, Kit225, with
IL-2 resulted in the rapid activation of
microtubule associated protein-2 kinase ( MAPK ), as demonstrated by the tyrosine phosphorylation of p42erk2, the reduced mobility of MAPK in SDS-PAGE gels, and the increased ability of lysates from these cells to phosphorylate myelin basic protein ... These results demonstrate that
IL-2 stimulation
results in the activation of
MAPK and p90rsk and that this activation occurs in a PKC independent manner
Rao et al., Cell Growth Differ 1995
(Lymphoma, T-Cell) :
Rapid
activation of
mitogen activated protein kinase and p21ras by prolactin and
interleukin 2 in rat Nb2 node lymphoma cells
Pahlavani et al., Frontiers in bioscience : a journal and virtual library 1998
:
In addition, preliminary results suggest that activation of the upstream signaling molecules, the mitogen activated protein kinase (
MAPK ) signaling cascade, may
play a role in the enhancement of
IL-2 transcription
Gadina et al., J Immunol 1998
:
Finally, SHP-2 expression amplified STAT dependent transcriptional activation whereas a dominant negative allele inhibited transactivation and the
IL-2 induced activation of
MAPK ( mitogen activated protein kinase )
Kirk et al., Cell Immunol 1998
:
Stimulation of the ERK (
MAPK ) pathway in T-lymphocytes
contributes to cell activation and
IL-2 production